To direct the Secretary of Health and Human Services to require public institutions of higher education that receive grants under the Medical Student Education program to include training for medical students relating to menopause in the curriculums of such institutions, and for other purposes.
Summary
HR9273 is a kitchen-table bill that directs medical schools receiving certain federal grants to include menopause training in their curricula. No direct market impact: zero appropriation, no mandate on private entities, and no immediate revenue effect for any publicly traded company.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR9273 is an early-stage education mandate with no funding or private-sector impact.
- 2.No publicly traded company faces a direct revenue or cost change from this bill.
- 3.Retail investors should ignore this bill for portfolio decisions; there are no material implications.
Market Implications
This bill does not affect any public company's revenue, costs, or competitive position. There are no market implications for any sector or ticker.
Full Analysis
- On June 11, 2026, Rep. Valerie Foushee (D-NC4) introduced HR9273, which would require public medical schools receiving grants under the Medical Student Education program to include menopause training. The bill was referred to the House Committee on Energy and Commerce — a standard first step. No further action has occurred. 2) The bill is an authorization-only measure with zero appropriated dollars. It does not create a spending program, tax credit, or procurement requirement. The mechanism is a curriculum mandate on grant-receiving institutions, not a market intervention. No money flows to private companies. 3) Structural winners and losers: This bill affects medical education accreditation, not drug pricing, device sales, or insurance reimbursement. Companies like $JNJ (menopause hormone therapy), $LLY (bone health), or $UNH (insurance coverage) see no revenue change because the bill does not alter prescription volume, coverage mandates, or provider reimbursement. 4) No real market data is available for this bill — it had zero price-relevant impact. 5) The bill must clear committee, pass the House, pass the Senate, and be signed by the President before any curriculum changes occur. Even if enacted, implementation is years away and applies only to federal grant recipients. Passage probability in the current Congress is low given the narrow scope and early stage.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
POTOMAC ELECTRIC POWER CO: $117M Department of Health and Human Services Contract
PA DEPARTMENT OF HUMAN SERVICES: $1.0B Department of Health and Human Services Grant
THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA (THE GLOBAL FUND): $1.8B Department of State Federal Award
DEPARTMENT OF HUMAN SERVICES HAWAII: $2.2B Department of Health and Human Services Grant
KANSAS DEPARTMENT OF HEALTH & ENVIRONMENT: $4.6B Department of Health and Human Services Grant
NEW MEXICO HEALTH CARE AUTHORITY: $9.4B Department of Health and Human Services Grant
HEALTH SERVICES KENTUCKY CABINET FOR: $18.2B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $4.1B Department of Health and Human Services Federal Award
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →